Update your browser

Your browser (Internet Explorer) is out of date.

Update your browser for more security, comfort and the best experience on this site.

MicuRx Pharmaceuticals, Inc.

The MicuRx mission is to bring safer and effective antibacterial products for therapy of Gram-positive and Gram-negative infections to healthcare providers globally.

3916 Trust Way, Hayward, CA 94545, United States

Profile Navigation
This is a community generated profile. If you would like to claim it, please contact us.

About

Our Company

In 2015, MicuRx reported successful results for its lead compound, MRX-1, from two oral Phase 2 studies in complicated skin and soft tissue infections, including methicillin-resistant Staphylococccus aureus (MRSA) infections, conducted in China and the USA. MRX-1 is currently in Phase 3 trials in China with additional clinical tests planned for the US.

Markets

areas of proficiency

Company Type

Choose Company Type

Cancel

Company Size

11 - 30

Choose Company Size

Cancel

Contact Info

get in touch

  • Location:

    Other: 3916 Trust Way, Hayward, CA 94545, United States